ZMapp: Clinical Trials

2 trials of ZMapp, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1
Phase 21Completed 1

Follow ZMapp: new trials by email Literature Review of ZMapp trials Research Report on ZMapp

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
B/Current Standard of Care Plus ZMapp, A/Current Standard of Care Alone - Ebola Virus Infection
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)722015-03-132019-06-05
Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers
ZMAPP - Healthy
Phase 1WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2015-03-112019-12-16

Conditions studied

Hemorrhagic Fever, Ebola (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)

Countries

Guinea (1)  ·  Liberia (1)  ·  Sierra Leone (1)  ·  United States (1)

Top investigators

Richard T Davey, M.D. (2)

Results publications

PMID 27732819